Back to Search
VANESSA ALTIERI, M.D
M.D
General Practice Physician
NPI: 1245393594Individual
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
14987(PR)
Research & Publications (20)
Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma.
PMID 19440021·Urol Int·2009
4-observational
Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
PMID 19443884·Int J Surg Pathol·2009
8-other
Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer.
PMID 19309489·Histopathology·2009
8-other
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients.
PMID 19262371·Anticancer Drugs·2009
3-trial
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study.
PMID 17360103·Eur Urol·2007
3-trial
Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
PMID 17521678·J Urol·2007
4-observational
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer.
PMID 17320676·Urology·2007
3-trial
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience.
PMID 17316970·Eur Urol·2007
4-observational
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
PMID 17207909·Eur Urol·2007
8-other
Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder. A study from Gruppo Studi Tumori Urologici Foundation.
PMID 16888422·Urol Int·2006
4-observational
[Fixed points and open questions in the treatment of superficial bladder carcinoma].
PMID 17491547·Arch Ital Urol Androl·2006
8-other
Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
PMID 17177989·BMC Cancer·2006
4-observational
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells.
PMID 16989777·Biochem Pharmacol·2006
8-other
Proposal for revision of the TNM classification system for renal cell carcinoma.
PMID 16208703·Cancer·2005
4-observational
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
PMID 16116599·Cancer·2005
4-observational
Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report.
PMID 16048646·BMC Cancer·2005
5-case
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma.
PMID 16007683·Cancer·2005
8-other
cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers.
PMID 15895411·J Cell Physiol·2005
4-observational
Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility.
PMID 15879886·J Urol·2005
7-preclinical
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer.
PMID 15548437·Eur Urol·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5-19 AVE SANTA ANA, URB. ALTURAS DE TORRIMAR
GUAYNABO, PR 00969 - Phone
- (787) 306-6359
Quick Facts
- NPI
- 1245393594
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile